Bioptimus nabs $41m to develop 'ChatGPT for biology'
- A French AI startup, Bioptimus, has raised $41 million to develop a foundational AI model for biology, bringing its total funding to $76 million since its founding last year.
- The funding round was led by U.S. Venture capital firm Cathay Innovation, with participation from several other investors.
- Bioptimus launched H-Optimus-0, an open source foundation model for pathology, aimed at improving disease research and diagnosis.
- CEO Jean-Philippe Vert stated that the goal is to simulate biology to predict disease outcomes and develop effective treatments.
Insights by Ground AI
Does this summary seem wrong?
Coverage Details
Total News Sources0
Leaning Left0Leaning Right0Center2Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage